Search
Anselamimab
go.drugbank.com/drugs/DB17492InvestigationalSynonyms: Immunoglobulin g1, anti-(human amyloid fibril) (human-mus musculus monoclonal cael-101 .gamma.1-chain), disulfide with human-mus musculus monoclonal cael-101 .kappa.-chain, dimerProthrombin
go.drugbank.com/drugs/DB11311ApprovedInvestigationalProthrombin Complex Concentrate (Human), is indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.
Mixtures: COFACT 250 IU/10 ML IV ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADET, COFACT 500 IU/20 ML IV ENJEKSIYON IÇIN TOZ IÇEREN FLAKON, 1 ADETPolatuzumab vedotin
go.drugbank.com/drugs/DB12240ApprovedInvestigational[L6658] Polatuzumab vedotin was granted accelerated FDA approval on June 10, 2019 [A254936] and was approved by Health Canada on July 9, 2020.[L44141] … humanized immunoglobulin G1 (IgG1) monoclonal antibody specific for human CD79b (polatuzumab), MMAE, and protease-cleavable linker called maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl (mc-vc-PAB
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesRabies immune globulin, equine
go.drugbank.com/drugs/DB16574InvestigationalProducts: วินแร็บ 1000 ยูนิตสากลAdenine
go.drugbank.com/drugs/DB00173ApprovedInvestigationalNutraceuticalA purine base and a fundamental unit of adenine nucleotides.
Mixtures: HEPATAMINE %8 500 ML(SETLI), HEPATAMINE %8 500 ML(SETSIZ)Acid Base Imbalance
go.drugbank.com/conditions/DBCOND0046840Drugs: Sodium phosphate, monobasicSynonyms: Acid-Base Imbalance, Acid Base ImbalanceTetanus immune globulin, equine
go.drugbank.com/drugs/DB16573InvestigationalProducts: เท็ททานัส แอนตี้ท็อกซิน 1000 ยูนิตสากล บีพีFluorocholine F-18
go.drugbank.com/drugs/DB15887InvestigationalProducts: IASOcholine 1 GBq/ml - Injektionslösung, Fluorochol 222 MBq/ml InjektionslösungCerivastatin
go.drugbank.com/drugs/DB00439ApprovedWithdrawnIt has also been withdrawn from the Canadian market.[A669,L43942]
Categories: Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 SubstratesOmbitasvir
go.drugbank.com/drugs/DB09296ApprovedInvestigationalOmbutasvir is also available as a fixed-dose combination product with [DB09297] and [DB00503] as the FDA- and Health Canada-approved product Technivie. … Ombutasvir first came on the market as a fixed-dose combination product with [DB09183], [DB09297], and [DB00503] as the FDA-approved product Viekira Pak.
Synonyms: dimethyl ([(2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis{(4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl[(2S)-3-methyl-1-oxobutane-1,2-diyl]})biscarbamateMixtures: VIEKIRAX 12.5 MG/75 MG/50 MG FILM KAPLI TABLET ,56 TABLET